April 17, 2025, 11:20 am
Two reports detail a rapidly expanding measles outbreak in the United States with experts warning that the true number of cases may far exceed official figures. One account highlights how anti-vaxxer activists are exploiting the crisis by peddling expensive “treatment” protocols and promoting unsubstantiated bioweapon claims, while the other, from CDC sources, lays out confirmed case counts and testing shortfalls across multiple states. Together, they paint a concerning picture of public health and misinformation amid the unfolding outbreak.
Reddit: r/ContagionCuriosity, r/TrueReddit, r/politics
Bluesky: @gottalaff.bsky.social, @jenlucpiquant.bsky.social, @fife4europe.bsky.social, @crof.bsky.social, @derekberes.bsky.social
Activists affiliated with Robert F. Kennedy, Jr. are selling a "measles treatment and prevention protocol" for hundreds of dollars, including supplements supposedly formulated by AI.
Measles Outbreak Likely Bigger Than Thought: CDC Authored by Zachary Stieber via The Epoch Times (emphasis ours), The measles outbreak that started in Texas this year is likely larger than reported, a U.S. Centers for Disease Control and Prevention official said on April 15. A measles...
permalink / 10 stories from 4 sources in 6 days ago #cybersecurity #innovation #biotech #digitalhealth #dataprivacy
U.S. officials decried the European Commission’s $570 million fine on Apple, dismissing it as economic extortion aimed squarely at American innovation. The White House warned that extraterritorial regulations undermining U.S. companies will not be tolerated in a climate of rising transatlantic tech tensions. More...
In a move that might make industry insiders raise an eyebrow, OpenAI has expressed its willingness to acquire Google’s Chrome browser if the tech giant is forced to divest. This bold declaration underscores OpenAI’s ambition to expand its ecosystem while playfully challenging the status quo in the tech world. More...
In a high‐stakes courtroom showdown, the Department of Justice is zeroing in on Google’s Samsung Gemini AI deal, arguing that it extends the search giant’s monopoly power. The trial has ignited fresh regulatory scrutiny as Google defends its competitive stance with detailed counterarguments. More...
Perplexity’s chief business officer Dmitry Shevelenko has taken a defiant stance amid legal scrutiny over Google’s alleged restrictive deals. Subpoenaed to testify in a trial on Google’s search monopoly, he seized the chance to pitch the audacious idea of buying Chrome, criticizing tactics that stifle his company’s AI distribution. More...
TSMC has unveiled its cutting-edge 1.4nm process aimed for production in 2028, promising notable performance boosts and power savings for future Apple silicon. This breakthrough underscores the relentless pursuit of chip innovation as Apple prepares for its next-generation device lineup. More...
Linux io_uring vulnerability exposes stealthy rootkit risk (1 hour ago)
Chainguard Secures $3.5B Valuation with Massive Series D Funding (9 hours ago)
Blue Shield data breach exposes 4.7M member records to Google (22 hours ago)
VW and Uber join forces for US robotaxi rollout (1 hour ago)
Chainguard Secures $3.5B Valuation with Massive Series D Funding (9 hours ago)
Sesh lands $7M to amp up fan engagement and membership perks (46 hours ago)
Dire Wolves De-Extinction Controversy Unites Expert Critiques and Claims (2 days ago)
Trump’s Tariff Measures Spark Strong China, JPMorgan, South Korea Reactions (3 days ago)
Federal Covid.gov Site Redirect Sparks Lab Leak Theories (5 days ago)
Blue Shield data breach exposes 4.7M member records to Google (22 hours ago)
Bluesky debuts revamped verification with blue checkmarks (43 hours ago)
Controversial Texas doctor treats measles while battling his own affliction (2 days ago)
WhatsApp rolls out advanced chat privacy updates (20 hours ago)
Blue Shield data breach exposes 4.7M member records to Google (22 hours ago)
EU Slaps Hefty Digital Markets Fines on Apple and Meta (27 hours ago)
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.